Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2NET 2Head & Neck 2Gastrointestinal 2Endocrine 2Sarcoma 1

Conditions

Sarcoma 7Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Thyroid Neoplasms 3Thyroid Cancer, Papillary 3Salivary Gland Neoplasms 3Head and Neck Neoplasms 3Gastrointestinal Stromal Tumors 3Central Nervous System Neoplasms 3Breast Neoplasms 3Brain Neoplasms 3Thyroid Diseases 2Thoracic Neoplasms 2Respiratory Tract Neoplasms 2Respiratory Tract Diseases 2Ovarian Neoplasms 2Neuroendocrine Tumors 2Neuroblastoma 2Neoplasms by Site 2Melanoma 2Medulloblastoma 2Lung Neoplasms 2Lung Diseases 2Glioma 2Endocrine System Diseases 2Endocrine Gland Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Bronchogenic 2Bronchial Neoplasms 2

Interventions

repotrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Neuroectodermal Tumors × Sarcoma × Clear all
NCT03093116 2026-05-27

TRIDENT-1

Turning Point Therapeutics, Inc.

Phase 1/2 Recruiting
500 enrolled 2 FDA
EndocrineGastrointestinalHead & NeckNETSarcomaThoracic

Adenocarcinoma, Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Colonic Diseases, Colonic Neoplasms, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Sarcoma, Thoracic Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Neuroectodermal Tumors, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡